NCT02480803View on ClinicalTrials.gov

INfusion VErsus STimulation in Parkinson's Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

December 19, 2014

Primary Completion Date

December 7, 2021

Study Completion Date

January 26, 2024

Conditions
Parkinson's Disease
Interventions
DRUG

Continuous intrajejunal infusion of levodopa-carbidopa

Continuous delivery of levodopa-carbidopa intestinal gel through an intrajejunal percutaneous tube (Duodopa, CLI, CILI)

DEVICE

deep brain stimulation

Bilateral deep brain stimulation (DBS) of the subthalamic nucleus (STN)

Trial Locations (1)

1100ZZ

Academic Medical Center, Amsterdam

All Listed Sponsors
collaborator

ZonMw: The Netherlands Organisation for Health Research and Development

OTHER

lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

NCT02480803 - INfusion VErsus STimulation in Parkinson's Disease | Biotech Hunter | Biotech Hunter